Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study-Reference-Cited by-同舟云学术

Effects of Add-On Ultramicronized N-Palmitol Ethanol Amide in Patients Suffering of Migraine With Aura: A Pilot Study

Published:2018-08-17 Issue: Volume:9 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Chirchiglia Domenico,Cione Erika,Caroleo Maria C.,Wang Minyan,Di Mizio Giulio,Faedda Noemi,Giacolini Teodosio,Siviglia Serena,Guidetti Vincenzo,Gallelli Luca

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference43 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2016

2. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet,2017

3. GBD 2015: migraine is the third cause of disability in under 50s;Steiner;J Headache Pain,2016

4. A questionnaire-based study on prevalence and treatment of headache in young children;Gallelli;J Headache Pain,2005

5. The international classification of headache disorders;Headache;Cephalalgia,2018

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain;Pharmacology & Therapeutics;2024-06

2. Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis;Nutrients;2024-05-28

3. The Endocannabinoid Activity Remodulation for psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis;2024-03-29

4. Non-Pharmacological Treatments in Paediatric Migraine;Journal of Clinical Medicine;2024-02-23

5. Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants—A Double-Blind Randomised Controlled Study;Pharmaceuticals;2024-01-23